Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes (Q40234430)

From Wikidata
Jump to navigation Jump to search
scientific article published on March 2007
edit
Language Label Description Also known as
English
Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes
scientific article published on March 2007

    Statements

    Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes (English)
    Joshua A Ray
    William J Valentine
    Stéphane Roze
    Jan McKendrick
    Daniel M D Tucker
    Volker Foos
    Andrew J Palmer
    1 March 2007
    609-622

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit